, /PRNewswire/ -- The global digital pathology market size is estimated to grow by .12 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 16.
98% during the forecast period. Growing adoption of iot infrastructure among laboratories is driving market growth, with a trend towards integration of ai into digital pathology systems. However, issues regarding privacy and safety of a digital database poses a challenge.
Key market players include 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Co Diagnostics Inc.
, Corista, Danaher Corp., F. Hoffmann La Roche Ltd.
, General Electric Co., Hamamatsu Photonics KK, Huron Digital Pathology, Indica Labs Inc., Inspirata Inc.
, Kanteron Systems SLU, Koninklijke Philips N.V., Mikroscan Technologies Inc.
, Objective Pathology Services, Olympus Corp., Proscia Inc., Sectra AB, Visiopharm AS, and XIFIN Inc.
. Get a detailed analysis on regions, market segments, customer landscape, and companies - The digital pathology market is experiencing significant growth due to the integration of AI technology. Vendors are developing AI-powered software for image analysis, automation, and decision-making in digital pathology workflow.
HALO AI and Oncotopix are commercially available AI-based platforms. Other vendors, like Huron Technologies, Danaher, and Philips, are continuously improving AI platforms, increasing the availability of AI-integrated systems. This advancement addresses the shortage of trained pathology.